veranova

Executive Summary

Veranova is a privately held Contract Development and Manufacturing Organization (CDMO) based in Malvern, Pennsylvania, founded in 2014. The company specializes in the development and commercial-scale manufacturing of complex active pharmaceutical ingredients (APIs), highly potent APIs (HPAPIs), and drug linkers used in Antibody-Drug Conjugates (ADCs). With a focus on small molecules and advanced modalities, Veranova serves pharmaceutical and biotechnology clients from early-stage development through to commercial production. The company has established itself as a key partner in the growing ADC and HPAPI markets, leveraging its expertise in handling hazardous and potent compounds. While Veranova operates in a competitive CDMO landscape, its specialization and stage of being 'approved' indicate existing regulatory clearances and ongoing commercial supply agreements. The company's growth is driven by increasing demand for targeted therapeutics and outsourcing of complex manufacturing.

Upcoming Catalysts (preview)

• Q4 2026Capacity expansion for ADC linker manufacturing75% success
• Q3 2026New multi-year supply agreement with a top pharma60% success
• Q2 2026FDA approval for additional HPAPI manufacturing lines80% success